Description

Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH), studied for its ability to stimulate endogenous growth hormone production. Initially developed and approved for the reduction of visceral adipose tissue in specific clinical populations, it is now being investigated in preclinical and clinical research settings for its potential effects on fat metabolism, muscle physiology, cognitive processes, and metabolic regulation. Studies continue to explore its impact on lipid profiles, insulin sensitivity, and overall endocrine function. For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.